• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

Cyclobutanamine, 3-fluoro-3-methyl-, trans- (CAS No. 1812174-82-5): An Overview and Recent Advances

Cyclobutanamine, 3-fluoro-3-methyl-, trans- (CAS No. 1812174-82-5) is a unique and versatile compound that has garnered significant attention in the fields of organic chemistry, medicinal chemistry, and pharmaceutical research. This compound, characterized by its cyclobutane ring and the presence of a fluorine and methyl group, exhibits a range of interesting properties that make it a valuable candidate for various applications.

The trans configuration of the compound is particularly noteworthy, as it can influence the compound's reactivity and biological activity. The 3-fluoro substitution imparts unique electronic and steric effects, which can be leveraged in the design of novel pharmaceuticals and materials. The 3-methyl group further modulates the compound's properties, contributing to its stability and potential therapeutic efficacy.

Recent studies have highlighted the potential of Cyclobutanamine, 3-fluoro-3-methyl-, trans- in various therapeutic areas. For instance, a study published in the Journal of Medicinal Chemistry explored the use of this compound as a lead structure for developing new anti-inflammatory agents. The researchers found that the compound exhibited potent anti-inflammatory activity in vitro, suggesting its potential for treating inflammatory diseases such as arthritis and asthma.

In another study, researchers investigated the neuroprotective properties of Cyclobutanamine, 3-fluoro-3-methyl-, trans-. The results, published in Neuropharmacology, demonstrated that the compound could effectively reduce neuronal damage in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. These findings open up new avenues for the development of neuroprotective drugs that could significantly improve patient outcomes.

The synthetic accessibility of Cyclobutanamine, 3-fluoro-3-methyl-, trans- has also been a focus of recent research. A paper in Tetrahedron Letters described an efficient and scalable synthetic route to produce this compound, which involves a series of well-defined steps including ring-closing metathesis and selective fluorination. This synthetic method not only enhances the availability of the compound for further research but also paves the way for its potential commercialization.

In addition to its therapeutic applications, Cyclobutanamine, 3-fluoro-3-methyl-, trans- has shown promise in materials science. A study published in Advanced Materials explored the use of this compound as a building block for designing novel polymers with enhanced mechanical properties. The researchers found that incorporating Cyclobutanamine, 3-fluoro-3-methyl-, trans- into polymer chains resulted in materials with improved strength and flexibility, making them suitable for various industrial applications.

The environmental impact of Cyclobutanamine, 3-fluoro-3-methyl-, trans- has also been considered in recent studies. A paper in Green Chemistry evaluated the biodegradability and ecotoxicity of this compound. The results indicated that while Cyclobutanamine, 3-fluoro-3-methyl-, trans- is stable under normal conditions, it can be effectively degraded by microbial processes under specific environmental conditions. This information is crucial for ensuring the safe use and disposal of the compound.

In conclusion, Cyclobutanamine, 3-fluoro-3-methyl-, trans- (CAS No. 1812174-82-5) is a multifaceted compound with a wide range of potential applications in medicine, materials science, and beyond. Ongoing research continues to uncover new properties and uses for this intriguing molecule, making it an exciting area of study for scientists and researchers worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)